Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 6 November 2025 - 14:15

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/lenalidomide-mylan

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters